CREBBP and acute myeloid leukemia: Consequently, p300/CBP inhibitors such as A485 and CCS1477 predominantly induced cell cycle arrest and exhibited enhanced cytotoxicity against AML cell lines harboring the FLT3-ITD mutation compared with those with WT or null FLT3.